Skip to content

A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting.

A Single Centre Randomized Control Trial of Donor Site Wound Dressing After Split Thickness Skin Grafting

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06044519
Enrollment
90
Registered
2023-09-21
Start date
2022-08-01
Completion date
2023-02-28
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Donor Site Complication, Skin Graft Scar

Brief summary

The goal of this clinical trial\] is to compare different types of dressings used and there outcomes on STSG donor site wound. The main question\[s\] it aims to answer are: * the effectiveness of different donor site dressings and their adverse outcomes * the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze

Interventions

BIOLOGICALdifferent types of dressings

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

Sponsors

Dow University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* . Patients of aged 18 years and above of either gender underwent single donor-site wounds after split-skin grafting and surface area larger than 10 cm2 were included in the study

Exclusion criteria

* Patients on chemotherapy or corticosteroids were excluded from the study. Non-probability consecutive sampling was employed

Design outcomes

Primary

MeasureTime frameDescription
to asses the effective of dressings by measuring itching , pain and scarringsix monthscaring by POSAS SCORE, pain and itcting by VISUAL ANALOGUE SCAORE.

Secondary

MeasureTime frameDescription
patient satisfaction for scarsix monthslikert scale
any complicationssix monthsinfection, hypergranulation, allergy

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026